Rasagiline Tartrate

CHEMBL6067988 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
492.6 g/mol
LogP
Phase
4

A tartrate salt form of rasagiline with the same therapeutic properties. A MAO-B inhibitor used to treat Parkinson's disease, either alone in early stages or combined with levodopa in more advanced disease, by increasing dopamine levels in the brain.

Molecular Weight

492.6000 g/mol

TPSA

139.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C#CCN[C@@H]1CCc2ccccc21.C#CCN[C@@H]1CCc2ccccc21.O=C(O)[C@H](O)[C@@H](O)C(=O)O

InChI

InChI=1S/2C12H13N.C4H6O6/c2*1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;5-1(3(7)8)2(6)4(9)10/h2*1,3-6,12-13H,7-9H2;1-2,5-6H,(H,7,8)(H,9,10)/t2*12-;1-,2-/m111/s1

Molecular Formula

C28H32N2O6

HBD / HBA

6 / 8

Rotatable Bonds

7

Heavy Atoms

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A tartrate salt form of rasagiline with the same therapeutic properties. A MAO-B inhibitor used to treat Parkinson's disease, either alone in early stages or combined with levodopa in more advanced disease, by increasing dopamine levels in the brain.

Yes, Rasagiline Tartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6067988. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71550735. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.